Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX

Human Gene Therapy

Volumn 8, Issue 2, 1997, Pages 125-135

  Chen, Lin ^a   Perlick, Haley ^a   Morgan, Richard A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; MESSENGER RNA;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FIBROBLAST; GENE CASSETTE; GENE EXPRESSION; GENETIC TRANSDUCTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL; LONG TERMINAL REPEAT; NONHUMAN; NORTHERN BLOTTING; PARTIAL THROMBOPLASTIN TIME; PROMOTER REGION; PROTEIN EXPRESSION; RABBIT; RETROVIRUS;

EID: 0031039171     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.2-125     Document Type: Article

References (35)

1. ADAM, M.A., OSBORNE, W.R.A., and MILLER, A.D. (1995). R-region cDNA inserts in retroviral vectors are compatible with replication and high-level protein synthesis from the insert. Hum. Gene Ther. 6, 1169-1176.
2. AXELROD, J.H., READ, M.S., BRINKHOUS, K.M., and VERMA, I.M. (1990). Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc. Natl. Acad. Sci. USA 87, 5173-5177.
3. BODINE, D.M., MCDONAGH, K.T., BRANDT, S.J., NEY, P.A., AGRICOLA, B., BYRNE, E., and NIENHUIS, A.W. (1990). Development of a high-liter retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87, 3738-3742.
4. CHALLITA, P.M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91, 2567-2571.
5. CHALLITA, P., SKELTON, D., EL-KHOUEIRY, A., YU, X., WEINBERG, K., AND KOHN, D.B. (1985). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69, 748-755.
6. CHIORINI, J.A, WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541.
7. CHUAH, M.K.L., VANDENDRIESSCHE, T., and MORGAN, R.A. (1995). Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. Hum. Gene Ther. 6, 1363-1377.
8. COUTURE, L.A., MULLEN C.A., and MORGAN, R.A. (1994). Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression. Hum. Gene Ther. 5, 667-677.
9. CROSSLEY, M., and BROWNLEE, G.G. (1990). Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Science 345, 444-446.
10. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895.
11. DANOS, O., and HEARD, J.M. (1992). Recombinant retroviruses as tools for gene transfer to somatic cells. Bone Marrow Transplant. 9, 131-138.
12. DARLINGTON, G.J. (1987). Liver cell lines. Methods Enzymol. 151, 19-38.
13. DICHEK, D.A., BRATTHAUER, G.L., BEG, Z.H., ANDERSON, K.D., NEWMAN, K.D., ZWIEBEL, J.A., HOEG, J.M., and ANDERSON, W.F. (1991). Retroviral vector mediated in vivo expression of low density lipoprotein receptors in the watanabe heritable hyperlipidemic rabbit. Somat. Cell Mol. Genet. 17, 287-301.
14. FANG, B., EISENSMITH, R.C., WANG, H., KAY, M.A., CROSS, R.E., LANDEN, C.N., GORDON, G., BELLINGER, D.A., READ, M.S., HU, P.C., BRINKHOUS, K.M., and WOO, S.L.C. (1995). Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6, 1039-1044.
15. FLOTTE, T.R., and CARTER, B.J. (1995). Adeno-associated virus vectors for gene therapy. Gene Ther. 2, 357-362.
16. GERRARD, A.J., HUDSON, D.L., BROWNLEE, G.G., and WATT, F.M. (1993). Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genet. 3, 180-184.
17. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia B: sustained partial correction in factor IX deficient dogs. Science 262, 117-119.
18. KOTIN, R.M. (1994). Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5, 793-801.
19. KURACHI, K., KURACHI, S., and YAO, S. (1993). Biology of Factor IX. Blood Coagul. Fibrinol. 4, 953-974.
20. LAUGHLIN, C.A., TRATSCHIN, J., COON, H., and CARTER, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73.
21. LOZIER, J.N., and BRINKHOUS, K.M. (1994). Gene therapy and the hemophilias. J. Am. Med. Assn. 271, 47-51.
22. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). A safe packaging cell line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
23. MCLACHLIN, J.R., MITTEREDER, N., DAUCHER, M.B., KADAN, M., and EGLITIS, M.A. (1993). Factors affecting retroviral vector function and structural integrity. Virology 195, 1-5.
24. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retroviral packaging cell lines to avoid recombination leading to helper virus reproduction. Mol. Cell. Biol. 6, 2895-2903.
25. MORGAN, R.A., COUTURE, L., ELROY-STEIN, O., RAGHEB, J., MOSS, B., and ANDERSON, W.F. (1992). Retroviral vectors containing putative internal ribosome entry sites: development of apolycistronic gene transfer system and application of human gene therapy. Nucleic Acids Res. 20, 1293-1299.
26. PALMER, T.D., THOMPSON, A.R., and MILLER, A.D. (1989). Production of human factor IX in animal by genetically modified fibroblasts: Potential therapy for hemophilia B. Blood 72, 438-445.
27. PALMER, T.D., ROSMAN, G.J., OSBORNE, W.R.A., and MILLER, A.D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
28. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 9.31-9.58, 7.37-7.79.
29. SCHARFMANN, R., AXELROD, J.H., and VERMA, I.M. (1991). Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88, 4626-4630.
30. SMITH, T.A., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., MCCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
31. WALTER, J., YOU, Q., HAGSTROM, J.N., SANDS, M., and HIGH, K.A. (1996). Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc. Natl. Acad. Sci. USA 93, 3056-3061.
32. YAO, S., and KURACHI, K. (1992). Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. USA 89, 3357-3361.
33. YAO, S., WILSOM, J.M., NABEL, E.G., KURACHI, S., HACHIYA, H.L., and KURACHI, K. (1991). Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for human hemophilia B. Proc. Natl. Acad. Sci. USA 88, 8101-8105.
34. YAO, S., SMITH, K.J., and KURACHI, K. (1994). Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Ther. 1, 99-107.
35. ZHOU, J., QIU, X., LU, D., LU, J., and HSUEN, J.L. (1993). Long term expression of human of human factor IX cDNA in rabbits. Science in China (series B) 36, 33-41.